Is it go or NO go for S-nitrosylation modification-based therapies of cystic fibrosis transmembrane regulator trafficking?

Molecular Pharmacology

Volumn 70, Issue 4, 2006, Pages 1155-1158

  Zeitlin, Pamela L ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Park 316 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; MUTANT PROTEIN; NITRIC OXIDE; S NITROSOGLUTATHIONE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ACUTE CHEST SYNDROME; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CYSTIC FIBROSIS; DRUG MEGADOSE; ENDOPLASMIC RETICULUM; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GOLGI COMPLEX; HOMEOSTASIS; HUMAN; MUTATION; NITROSYLATION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN TRANSPORT; REVIEW; TREATMENT OUTCOME; WATER CONTENT; WILD TYPE;

CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; GENETIC VARIATION; HSP40 HEAT-SHOCK PROTEINS; HUMANS; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN PROCESSING, POST-TRANSLATIONAL; S-NITROSOGLUTATHIONE; VARIATION (GENETICS);

EID: 33748919836     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.029207     Document Type: Review

References (31)

1. Acton JD and Wilmott RW (2001) Phenotype of CF and the effects of possible modifier genes. Paediatr Respir Rev 2:332-339.
2. App EM, Baran D, Dab I, Malfroot A, Coffiner M, Vanderbist F, and King M (2002) Dose-finding and 24-h monitoring for efficacy and safety of aerosolized nacystelyn in cystic fibrosis. Eur Respir J 19:294-302.
3. - donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch Biochem Biophys 318:279-285.
4. Atz AM and Wessel DL (1997) Inhaled nitric oxide in sickle cell disease with acute chest syndrome. Anesthesiology 87:988-990.
5. Casas JP, Bautista LE, Humphries SE, and Hingorani AD (2004) Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation 109:1359-1365.
6. Coles BF and Kadlubar FF (2005) Human Alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease. Methods Enzymol 401:9-42.
7. Eaton P, Fuller W, and Shattock MJ (2002) S-Thiolation of HSP27 regulates its multimeric aggregate size independently of phosphorylation. J Biol Chem 277:21189-21196.
8. Gaston B, Reilly J, Drazen JM, Fackler J, Ramdev P, Arnelle D, Mullins ME, Sugarbaker DJ, Chee C, Singel DJ, et al. (1993) Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci USA 90:10957-10961.
9. Gaston B, Singel D, Doctor A, and Stamler JS (2006) S-Nitrosothiol signaling in respiratory biology. Am J Respir Crit Care Med 173:1186-1193.
10. Giustarini D, Rossi R, Milzani A, Colombo R, and Dalle-Donne I (2004) S-Glutathionylation: from redox regulation of protein functions to human diseases. J Cell Mol Med 8:201-212.
11. Gow AJ, Buerk DG, and Ischiropoulos H (1997) A novel reaction mechanism for the formation of S-nitrosothiol in vivo. J Biol Chem 272:2841-2845.
12. 2 chemosensitivity. Blood 99:1552-1555.
13. Hogg N, Singh RJ, Konorev E, Joseph J, and Kalyanaraman B (1997) S-nitrosoglutathione as a substrate for gamma-glutamyl transpeptidase. Biochem J 323 (Pt 2):477-481.
14. Jia L, Bonaventura C, Bonaventura J, and Stamler JS (1996) S-Nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature (Lond) 380:221-226.
15. Lipton AJ, Johnson MA, Macdonald T, Lieberman MW, Gozal D, and Gaston B (2001) S-Nitrosothiols signal the ventilatory response to hypoxia. Nature (Lond) 413:171-174.
16. Marshall HE, Merchant K, and Stamler JS (2000) Nitrosation and oxidation in the regulation of gene expression. FASEB J 14:1889-1900.
17. McIlwain CC, Townsend DM, and Tew KD (2006) Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 25:1639-1648.
18. Merlo CA and Boyle MP (2003) Modifier genes in cystic fibrosis lung disease. J Lab Clin Med 141:237-241.
19. Moya MP, Gow AJ, Califf RM, Goldberg RN, and Stamler JS (2002) Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn. Lancet 360:141-143.
20. Moya MP, Gow AJ, McMahon TJ, Toone EJ, Cheifetz IM, Goldberg RN, and Stamler JS (2001) S-Nitrosothiol repletion by an inhaled gas regulates pulmonary function. Proc Natl Acad Sci USA 98:5792-5797.
21. Palmer LA, Gaston B, and Johns RA (2000) Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: redox-dependent effect of nitrogen oxides. Mol Pharmacol 58:1197-1203.
22. Paolicchi A, Dominici S, Pieri L, Maellaro E, and Pompella A (2002) Glutathione catabolism as a signaling mechanism. Biochem Pharmacol 64:1027-1035.
23. Pawloski JR, Hess DT, and Stamler JS (2001) Export by red blood cells of nitric oxide bioactivity. Nature (Lond) 409:622-626.
24. Rao RK and Clayton LW (2002) Regulation of protein phosphatase 2A by hydrogen peroxide and glutathionylation. Biochem Biophys Res Commun 293:610-616.
25. + absorption across human nasal epithelial cells. J Cell Physiol 201:106-116.
26. Selverstone VJ, Doucette PA, and Zittin PS (2005) Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu Rev Biochem 74:563-593.
27. Spence MS, McGlinchey PG, Patterson CC, Allen AR, Murphy G, Bayraktutan U, Fogarty DG, Evans AE, and McKeown PP (2004) Endothelial nitric oxide synthase gene polymorphism and ischemic heart disease. Am Heart J 148:847-851.
28. Stamler JS, Toone EJ, Lipton SA, and Sucher NJ (1997) (S)NO Signals: translocation, regulation, and a consensus motif. Neuron 18:691-696.
29. Tirouvanziam R, Conrad CK, Bottiglieri T, Herzenberg LA, Moss RB, and Herzenberg LA (2006) High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis. Proc Natl Acad Sci USA 103:4628-4633.
30. Zaman K, Carraro S, Doherty J, Henderson EM, Lendermon E, Liu L, Verghese G, Zigler M, Ross M, Park E, et al. (2006) A novel class of compounds that increase cystic fibrosis transmembrane regulator expression and maturation in epithelial cells. Mol Pharmacol 70:1435-1442.
31. Zhang H, Schmidt BZ, Sun F, Condliffe SB, Butterworth MB, Youker RT, Brodsky JL, Aridor M, and Frizzell RA (2006) Cysteine string protein monitors late steps in cystic fibrosis transmembrane conductance regulator biogenesis. J Biol Chem 281:11312-11321.